These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18312222)

  • 1. A classification model for the Leiden proteomics competition.
    Hoefsloot HC; Smit S; Smilde AK
    Stat Appl Genet Mol Biol; 2008; 7(2):Article8. PubMed ID: 18312222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the statistical validity of proteomics based biomarkers.
    Smit S; van Breemen MJ; Hoefsloot HC; Smilde AK; Aerts JM; de Koster CG
    Anal Chim Acta; 2007 Jun; 592(2):210-7. PubMed ID: 17512828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach.
    Heidema AG; Nagelkerke N
    Stat Appl Genet Mol Biol; 2008; 7(2):Article5. PubMed ID: 18312219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest.
    Datta S
    Stat Appl Genet Mol Biol; 2008; 7(2):Article7. PubMed ID: 18312221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Support vector machine approach to separate control and breast cancer serum samples.
    Pham TV; van de Wiel MA; Jimenez CR
    Stat Appl Genet Mol Biol; 2008; 7(2):Article11. PubMed ID: 18312216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the random forest classification method to peaks detected from mass spectrometric proteomic profiles of cancer patients and controls.
    Barrett JH; Cairns DA
    Stat Appl Genet Mol Biol; 2008; 7(2):Article4. PubMed ID: 18312218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
    Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
    J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
    Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.
    Hong YJ; Wang XD; Shen D; Zeng S
    Acta Pharmacol Sin; 2008 Oct; 29(10):1240-6. PubMed ID: 18817630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALDI-TOF serum protein profiling for the detection of breast cancer.
    de Noo ME; Deelder A; van der Werff M; Ozalp A; Mertens B; Tollenaar R
    Onkologie; 2006 Nov; 29(11):501-6. PubMed ID: 17068384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principal component discriminant analysis.
    Fearn T
    Stat Appl Genet Mol Biol; 2008; 7(2):Article6. PubMed ID: 18312220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in the search for potential biomarkers by proteomics: application of principal component and discriminant analyses for two-dimensional maps evaluation.
    Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Páez de la Cadena M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):251-60. PubMed ID: 17071145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical Bayes logistic regression.
    Strimenopoulou F; Brown PJ
    Stat Appl Genet Mol Biol; 2008; 7(2):Article9. PubMed ID: 18312223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to distinguish healthy from diseased? Classification strategy for mass spectrometry-based clinical proteomics.
    Hendriks MM; Smit S; Akkermans WL; Reijmers TH; Eilers PH; Hoefsloot HC; Rubingh CM; de Koster CG; Aerts JM; Smilde AK
    Proteomics; 2007 Oct; 7(20):3672-80. PubMed ID: 17880000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
    Liu DH; Zhang LM; Feng WY
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
    [No Abstract]   [Full Text] [Related]  

  • 19. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
    Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of serum proteomics in breast cancer research].
    Zhu ZM; Hu XF; Zeng R
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):561-5. PubMed ID: 18210871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.